Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 47
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 2301 | CORN PRODUCTS DEVELOPMENT | 6 | 116.7% | 0 | 5 | 2022–2024 |
| 2302 | CRRC YANGTZE | 6 | 00% | 0 | 6 | 2022–2025 |
| 2303 | CSL BEHRING | 6 | 00% | 0 | 6 | 2023–2026 |
| 2304 | DAINICHISEIKA COLOR CHEMICALS MFG | 6 | 350% | 0 | 3 | 2022–2025 |
| 2305 | DCM SHRIRAM | 6 | 00% | 1 | 5 | 2022–2025 |
| 2306 | DE NORA PERMELEC | 6 | 466.7% | 0 | 2 | 2022–2025 |
| 2307 | DEBUT BIOTECHNOLOGY | 6 | 00% | 0 | 6 | 2025–2026 |
| 2308 | DELFI DIAGNOSTICS | 6 | 00% | 0 | 6 | 2023–2025 |
| 2309 | DELL PRODUCTS LP | 6 | 233.3% | 0 | 4 | 2021–2024 |
| 2310 | DEPUY IRELAND UNLIMITED | 6 | 233.3% | 0 | 4 | 2022–2025 |
| 2311 | DEWPOINT THERAPEUTICS | 6 | 00% | 5 | 1 | 2022–2024 |
| 2312 | DKS | 6 | 00% | 0 | 6 | 2022–2026 |
| 2313 | DOLBY VIDEO COMPRESSION | 6 | 233.3% | 0 | 4 | 2019–2025 |
| 2314 | DOMAIN THERAPEUTICS | 6 | 233.3% | 1 | 3 | 2021–2025 |
| 2315 | DONGGUAN POWERAMP TECHNOLOGY | 6 | 466.7% | 1 | 1 | 2022–2023 |
| 2316 | DORMAKABA DEUTSCHLAND | 6 | 00% | 0 | 6 | 2023–2023 |
| 2317 | DUALITY BIOLOGICS SUZHOU | 6 | 00% | 0 | 6 | 2023–2026 |
| 2318 | DUPONT SAFETY CONSTRUCTION | 6 | 00% | 0 | 6 | 2022–2025 |
| 2319 | DYNO NOBEL | 6 | 00% | 0 | 6 | 2023–2025 |
| 2320 | E CIRCUIT MOTORS | 6 | 00% | 1 | 5 | 2022–2025 |
| 2321 | EAGLEPICHER TECHNOLOGIES | 6 | 00% | 5 | 1 | 2023–2024 |
| 2322 | EAST END MEDICAL | 6 | 00% | 5 | 1 | 2022–2023 |
| 2323 | EASY RAIN I | 6 | 00% | 3 | 3 | 2023–2026 |
| 2324 | EATON ELECTRICAL | 6 | 00% | 0 | 6 | 2023–2023 |
| 2325 | ECOGENSUS | 6 | 00% | 2 | 4 | 2022–2023 |
| 2326 | EFEMORAL MEDICAL | 6 | 116.7% | 0 | 5 | 2020–2026 |
| 2327 | EJOT SE KG | 6 | 00% | 1 | 5 | 2022–2025 |
| 2328 | ELANCO ANIMAL HEALTH | 6 | 233.3% | 0 | 4 | 2021–2025 |
| 2329 | ELECTRASTEEL | 6 | 00% | 0 | 6 | 2023–2025 |
| 2330 | ELECTRICITE DE FRANCE | 6 | 00% | 0 | 6 | 2022–2026 |
| 2331 | ELKEM SILICONES USA | 6 | 583.3% | 0 | 1 | 2022–2024 |
| 2332 | ENERTECHNOS | 6 | 00% | 1 | 5 | 2022–2025 |
| 2333 | ENFABRICA | 6 | 00% | 3 | 3 | 2023–2024 |
| 2334 | ENGINEER AI | 6 | 00% | 0 | 6 | 2023–2024 |
| 2335 | ENVEDA THERAPEUTICS | 6 | 00% | 0 | 6 | 2025–2026 |
| 2336 | EOS ENERGY TECHNOLOGY HOLDINGS | 6 | 00% | 0 | 6 | 2023–2026 |
| 2337 | ERBE VISION | 6 | 00% | 0 | 6 | 2022–2024 |
| 2338 | EURENCO FRANCE | 6 | 00% | 0 | 6 | 2024–2026 |
| 2339 | EXTROVIS | 6 | 00% | 2 | 4 | 2022–2023 |
| 2340 | FAPON BIOTECH | 6 | 00% | 0 | 6 | 2022–2026 |
| 2341 | FASTCAP SYSTEMS | 6 | 00% | 0 | 6 | 2022–2023 |
| 2342 | FEDERAL MOGUL BURSCHEID | 6 | 00% | 0 | 6 | 2022–2026 |
| 2343 | FLUENCE ENERGY | 6 | 00% | 0 | 6 | 2025–2025 |
| 2344 | FOCKE KG | 6 | 00% | 1 | 5 | 2022–2024 |
| 2345 | FRAUSCHER SENSORTECHNIK | 6 | 116.7% | 0 | 5 | 2022–2025 |
| 2346 | FUJIAN CHANGTING GOLDEN DRAGON RARE EARTH | 6 | 00% | 0 | 6 | 2023–2023 |
| 2347 | FULBRIGHT MEDICAL | 6 | 233.3% | 0 | 4 | 2022–2025 |
| 2348 | GALECTO BIOTECH | 6 | 00% | 4 | 2 | 2022–2023 |
| 2349 | GARENA ONLINE | 6 | 00% | 0 | 6 | 2022–2022 |
| 2350 | GE VERNOVA TECHNOLOGY | 6 | 00% | 0 | 6 | 2025–2025 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →